Recently, we and others have offered evidence that LSD1 inhibition by TCP or genetic knockdown has promising anticancer effects in diverse cancer contexts including HNSCC.13,15,16 However, considering its low efficiency as monotherapy, TCP in combination with other anticancer chemicals might be synergistic to achieve more potent effects. Here, KDM1A is linked to head and neck squamous cell carcinoma.